Jim Cramer shines a spotlight on Novo Nordisk A/S (NVO) as “Canada’s backdoor” in a recent Insider Monkey report, highlighting the pharma giant’s daring strategies and thrilling growth prospects throughout North America
Browsing: Biotech
Astellas Pharma has launched an exciting new program offering dedicated lab space exclusively for Japanese biotech start-ups, designed to ignite their growth and fast-track their path to the global stage. This bold initiative is set to unleash innovation and boost international competitiveness like never before
4Moving Biotech has secured a €7.6 million grant from France 2030 to advance its innovative, first-in-class disease-modifying drug for osteoarthritis. This funding will support the company’s efforts to transform treatment options for this widespread condition.